You just read:

Bruker Announces Acquisition of Nucleic Acid Testing (NAT) Assays and Syndromic Panel Technology to Expand its MALDI Biotyper™ Platform

News provided by

Bruker Corporation

Nov 02, 2016, 16:05 ET